Second-line, low-dose, weekly paclitaxel in patients with Stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel Article

cited authors

  • Socinski, MA; Schell, MJ; Bakri, K; Peterman, A; Lee, JH; Unger, P; Yates, S; Hudgens, S; Kies, MS

Publication Date

  • September 15, 2002

webpage

published in

category

keywords

  • carboplatin
  • chemotherapy
  • lung carcinoma
  • nonsmall cell lung carcinoma
  • paclitaxel
  • second-line treatment

start page

  • 1265

end page

  • 1273

volume

  • 95

issue

  • 6